ICM
FLGT icon

Islay Capital Management’s Fulgent Genetics FLGT Stock Holding History

Islay Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,205
Closed -$75K – 289
2022
Q1 		$75K Sell
1,205
-262
-18% -$17.3K 0.06% 177
2021
Q4 		$148K Buy
1,467
+194
+15% +$17.1K 0.11% 114
2021
Q3 		$115K Buy
1,273
+141
+12% +$12.8K 0.09% 136
2021
Q2 		$104K Buy
+1,132
New +$90.4K 0.08% 141

Other funds holding FLGT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PWAM
Park West Asset Management San Francisco, California $1.18B AUM 47.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Islay Capital Management's FLGT Position: Q2 2022 in Review

Islay Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2022, closing a stake of 1,205 shares — an estimated $75K sold.

Islay Capital Management first reported a position in FLGT in Q2 2021 and held it in 4 quarters. The position peaked at $148K in Q4 2021. 262 funds tracked by Wall St. Rank hold FLGT as of Q2 2022.

  • Islay Capital Management reported no remaining Fulgent Genetics position as of Q2 2022 after selling out during the quarter.
  • Islay Capital Management sold 1,205 Fulgent Genetics shares in Q2 2022, an estimated $75K.
  • Islay Capital Management first reported a position in Fulgent Genetics in Q2 2021 and held it in 4 quarters.
  • Islay Capital Management's Fulgent Genetics position peaked at $148K in Q4 2021.
  • 262 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2022.

Based on Islay Capital Management's 13F filing for Q2 2022, filed 8 Aug 2022.